Canada sets probiotic labeling deadline
This article was originally published in The Tan Sheet
Probiotic product claims must comply by April 2010 with guidance Health Canada approved in April, which the Canadian Food Inspection Agency recently added to its rules. In an Oct. 1 letter to industry, CFIA's Food Safety and Consumer Protection Directorate advised that labels, advertisements and Web sites must comply with the probiotic labeling guidance within six months. The Guide to Food Labeling and Advertising distinguishes between strain-specific and general claims. Health Canada prohibits misleading or vague claims, and science directly applicable to a particular food must support strain-specific claims. The agency noted no specific strains have been accepted, but it will update its online list of strain-specific claims as they are reviewed and accepted
You may also be interested in...
The International Medical Device Regulators Forum, perhaps most notorious for its efforts to standardize audit processes between nations with its Medical Device Single Audit Program, is also focusing on harmonizing device reviews and adverse event codes.
Dr Reddy’s Laboratories has become the third Revlimid ANDA sponsor to settle patent litigation action with Bristol Myers Squibb’s Celgene. However, the Indian company will join Alvogen in not being able to launch before first settler Natco, which has partnered with Teva’s Watson.
Strides is expanding its presence in synthetic injectables via a new company, SteriScience, while keeping its biologics injectables business under Stelis. A head start with existing IP assets and those from a new joint venture with Brooks Labs will enable the fledgling firm to file its first ANDA in fiscal 2021, with break-even foreseen in two years.